CClinicalTrials.gg
CompletedNCT02251028Updated Nov 10, 2020

Value-based Cognitive Behavioral Therapy for Prevention of Chronic Whiplash-associated Disorders

An interventional study of Value-based cognitive-behavioral therapy in Musculoskeletal Disorders and Whiplash, sponsored by University of Southern Denmark. Completed at 1 site in Denmark. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2020-11-10.

Sponsored by University of Southern Denmark · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 1 year 8 months after the study started (first participant enrolled Jan 2013, registered Sep 2014).
Phase
Not applicable
Study type
Interventional
Enrollment
92
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The purpose of this study is to determine whether a specifically tailored value-based cognitive behavioural therapy program (V-CBT) is able to prevent the development of persistent disability, pain, and psychological distress if delivered within the first three months after a whiplash injury.

Read the detailed description

The primary objective of the present study is to test whether a specifically tailored value-based cognitive-behavioural therapy program (V-CBT) is able to prevent the development of persistent disability, pain, and psychological distress if delivered within the first three months after a whiplash injury. Methods. The current study is a two-armed randomized controlled study with a crossover design. Group A is scheduled for V-CBT within one week of randomization and group B with a delayed onset 3 months after randomization.

02

Conditions studied

  • Musculoskeletal Disorders
  • Whiplash

Keywords

  • whiplash, prevention, pain, cognitive-behavioural therapy
03

In context

Musculoskeletal Diseases

657 studies on the registry are indexed under Musculoskeletal Diseases; 159 are open to participants now.

This study's enrollment of 92 is above the median of 73 across 438 interventional studies indexed under Musculoskeletal Diseases.

Browse Musculoskeletal Diseases studies →

Lead sponsor

University of Southern Denmark is the lead sponsor of 327 studies on the registry; 45 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

  • 18 and 65-years-old
  • WAD level I-II.
  • 3-months post-injury
  • Disability in at least one important life domain (≥ 5 on the pain disability index) and moderate levels of pain (average pain intensity ≥ 4 on the NRS scale).
  • Meet at least one of the psychological risk criteria:
  • Elevated levels of pain catastrophizing, fear-avoidance-beliefs, symptoms of anxiety and/or depression, and posttraumatic stress symptoms.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
92 participants (actual)

Study arms

  • Active comparator
    Group A

    Group A receives value-based cognitive behavior therapy after randomization.

    Behavioral: Value-based cognitive-behavioral therapy

  • Active comparator
    Group B

    Group B receives value-based cognitive behavior therapy after 3 months.

    Behavioral: Value-based cognitive-behavioral therapy

Interventions

  • BehavioralValue-based cognitive-behavioral therapy

    The intervention is a manualized program specifically tailored for prevention of disability and psychological distress after whiplash injuries. The intervention is delivered by two trained clinical psychologists og consists of 10 weekly one-hour individual sessions.

06

What researchers measure

Primary outcomes

  1. Disability as measured by Pain Disability Index

    The PDI measures how pain interferes with daily life activities within 7 different domains. The 7 domains are rated from 0 (no disability) to 10 (worst disability). The scale shows good reliability and validity.

    Time frame: Change scores at 12- and 24-weeks after randomization

Secondary outcomes

  1. Pain by NDI

    Neck pain intensity and disability is measured with the Neck Disability Index (NDI; Vernon \& Mior, 1991). The NDI measures within 10 domains pain and how neck pain affects the ability to handle daily life activities such as personal care, lifting, reading, work, driving, sleeping, recreational activities, pain intensity, concentration, and headache. The total score range from 0 (no disability) to 100 (total disability).

    Time frame: Change scores at 12- and 24-weeks after randomization

  2. Pain by NRS

    Pain is also measured on four numerical pain rating scales (NRS) ranging from 0 (no pain) to 10 (worst possible pain). Patients mark their answers on each scale corresponding to their pain now, highest level of pain, lowest level of pain, and finally average pain over the past week (NRS: Turk \& Melzack, 2001).

    Time frame: Change scores at 12- and 24-weeks after randomization

  3. Fear of re-injury by TSK

    Fear of re-injury due to movement is measured with Tampa Scale for Kinesiophobia (TSK; Kori, Miller, \& Todd, 1990). TSK is a 17-item scale assessing fear of movement on a 4-point likert scale ranging from 17 to 68 with higher scores indicating higher levels of kinesiophobia. The scale is commonly used in various chronic pain samples and has good construct and predictive validity (Roelofs, Goubert, Peters, Vlayen, \& Crombes, 2004). The clinical cut-off score is set to ≥ 37.

    Time frame: Change scores at 12- and 24-weeks after randomization

  4. Pain-related catastrophizing by PCS

    Catastrophic thinking related to pain is measured with the Pain Catastrophizing Scale (PCS; Sullivan, Bishop, Pivik, 1995). The PCS-instructions ask participants to reflect on past painful experiences and to indicate the degree to which they experienced each of 13 thoughts or feelings when experiencing pain on a five-point Likert scale with (0 = not at all, 4 = all the time).

    Time frame: Change scores at 12- and 24-weeks after randomization

  5. Anxiety and depression by HADS

    To assess the level of anxiety and depressive symptoms, the Hospital Anxiety and Depression Scale is used (HADS; Zigmond \& Snaith, 1983). The scale consists of 14 items, 7 relating to anxiety (HADS-A) and 7 to depression (HADS-D) with responses ranging from 0 (no symptoms) to 3 (maximum impairment). A cut-off score of ≥ 8 on each subscale is used in order to include all possible cases of depression and anxiety as suggested by (Zigmond \& Snaith, 1983).

    Time frame: Change scores at 12- and 24-weeks after randomization

  6. PTSD-symptomatology

    PTSD-symptomatology is measured with the PTSD-8 (Hansen, Andersen, Armour, Elklit, Palic, \& Mackrill, 2010). The scale is a brief version of The Harvard Trauma Questionnaire part IV (HTQ-IV; Molicca, Caspi-Yavin, Bollini, \& Truong, 1992) and consists of 8 items on a four-point Likert scale (1 = not at all, 4 = very often). The items relate to the three core clusters in PTSD in DSM-IV: avoidance (2 items), intrusion (4 items), and hyperarousal (2 items). The scale has proven good psychometric properties in various trauma samples including whiplash injured (Hansen et al., 2010).

    Time frame: Change scores at 12- and 24-weeks after randomization

07

Study locations

1 site
  • University of Southern Denmark
    Odense, Syddanmark 5230, Denmark
08

References and documents

Publications

  • Andersen TE, Ravn SL, Roessler KK. Value-based cognitive-behavioural therapy for the prevention of chronic whiplash associated disorders: protocol of a randomized controlled trial. BMC Musculoskelet Disord. 2015 Sep 1;16:232. doi: 10.1186/s12891-015-0687-y. PubMed 26323830 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 10, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02251028
Lead sponsor
University of Southern Denmark
Responsible party
Tonny Elmose Andersen, phd. (MSc., Ph.D, University of Southern Denmark) — Principal investigator
First posted
Sep 26, 2014
Start date
Jan 2013
Primary completion
Oct 2018
Completion
Dec 2019
Last update
Nov 10, 2020

Study contacts

Tonny Elmose Andersen, MSc,Ph.D.
study director · Department of Psychology
Ask Elklit, professor
study director · Department of Psychology

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion